about
Misophonia: diagnostic criteria for a new psychiatric disorderAdjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomesRevisiting the Dexamethasone Suppression Test in unipolar major depression: an exploratory studySwitching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case seriesDrop-out and mood improvement: a randomised controlled trial with light exposure and physical exercise [ISRCTN36478292]Effects of Ginkgo biloba in dementia: systematic review and meta-analysisAltered frontal cortical volume and decision making in adolescent cannabis usersThe cognitive impact of the ANK3 risk variant for bipolar disorder: initial evidence of selectivity to signal detection during sustained attentionCognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trialsCognitive–behavioral therapy for bipolar disorderImpaired working memory and normal sustained attention in borderline personality disorderApathy in Alzheimer's DiseaseIncidence of Dementia, Alzheimer's Disease, and Vascular Dementia in Italy. The ILSA StudySystematic review and meta-analyses of randomized controlled trials examining tinnitus management.Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adultsMeta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in DepressionPharmacological interventions for preventing post-traumatic stress disorder (PTSD)Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working groupLength polymorphism in the Period 3 gene is associated with sleepiness and maladaptive circadian phase in night-shift workersPsychosocial interventions for self-harm in adultsSelf management interventions for type 2 diabetes in adult people with severe mental illnessChlorpromazine versus atypical antipsychotic drugs for schizophreniaVortioxetine for depression in adultsLithium for schizophreniaNeuropsychological and psychological interventions for people with newly diagnosed epilepsyPharmacological interventions for self-harm in adultsAntiglucocorticoid and related treatments for psychosisHaloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disordersReiki for depression and anxietyKetamine and other glutamate receptor modulators for depression in bipolar disorder in adultsPharmacological and psychosocial interventions for night eating syndrome in adultsKetamine and other glutamate receptor modulators for depression in adultsPsychological therapies for the treatment of mental disorders in low- and middle-income countries affected by humanitarian crisesNon-pharmacological interventions for depression in adults and children with traumatic brain injuryAntidepressants for the treatment of depression in people with cancerBehavioural and cognitive-behavioural therapy based self-help versus treatment as usual for depression in adults and adolescentsPostdischarge interventions for depressionPsychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescentsMelatonin and agomelatine for preventing seasonal affective disorderPsychological therapies for preventing seasonal affective disorder
P2860
Q21133740-05AC6C6E-06F1-4B0F-A385-003A142C2B8FQ21144599-9B3B62F3-CC0B-4A2E-AD10-51400FAB4C24Q21203924-DDDAE796-B7E8-4C3B-B0DB-2B21C698EF06Q21203936-9AF991EE-063A-4B0F-86F2-49588BF6B4A1Q21260300-FA8B129F-DCB7-417D-9A14-73B6FCDE88F0Q21261865-E97E32C0-DBF8-4B67-8166-9B9CE6D4676CQ21558374-19DE58AF-B702-46A7-B52B-347B7EBEAE18Q21560854-ED8CB719-1DCE-46BA-A702-B627A9744EA3Q22241101-864B2A20-EC26-4446-B451-023DC44940B6Q22241478-89190028-C8B8-4A8F-9F60-92C2A8CEF3E1Q22242328-4943D96E-69B7-4A30-9C92-82A30D086A35Q22250948-68F5DF3C-2774-476B-90B0-1431B0AEFA37Q22250949-E7830625-168A-4C36-9E63-1DF5464A8863Q22252888-3C3B98A7-631C-4025-BEBE-3085B34E08BBQ22252957-FB941A52-55EB-4135-A34E-DF18EF35339CQ22305455-B9286419-FE31-4B41-9979-6C792C68B319Q22337441-A97A6133-E56F-4DA0-AC90-A0715C416794Q23747515-03991332-EDCC-4ED5-920E-480128004240Q23911162-5CA4732D-855B-47DA-9A48-7937B4DBA3D9Q24185772-8B6CB01D-32BC-4D84-B10D-5860E90340C6Q24185857-E0C36EE8-2955-414B-ADEA-C5E84B3905DAQ24185922-8656C1BE-5047-4301-B61F-02ADDE119877Q24186313-6CA6B92D-E2F0-41EC-A7A2-E54008CE86A4Q24186325-F4985F23-6260-45D3-A1CC-F13F043BBBF6Q24186363-14E25DFE-A3B6-448C-9BE2-A7AA3C2A3FF5Q24186543-066BD04D-F0F4-4533-80E0-D11330FC7643Q24186594-F45EDA44-CAA5-4C73-BAE0-D83E9C919CA8Q24186601-7B046833-29C5-4998-BB0A-6BD656DF091CQ24186631-129F6DFF-9A26-495C-8B61-FFBBF39549AEQ24186726-E078DB57-E9A8-471A-864E-9DB0F16EB13DQ24186735-0DC2712A-0A61-4B3C-9224-734CBB6D752CQ24186746-F754489E-35DB-435D-84C2-209C79CBE394Q24186781-0DF8B071-DBD3-41AC-B2CC-BE08797A17DBQ24187124-3E6B623F-A704-490D-82A3-B957C21EEE97Q24187358-DC9C622F-118E-415F-968D-3C2BD1D487EBQ24187537-D56B9DA0-3751-42B0-A2D9-C1BBC3E24F2DQ24187631-736CFE69-3D7F-46B5-8D9E-58D3DF147797Q24187748-B7DE4BE8-4757-4B1C-A961-E26F628A9337Q24187803-11CF65B8-8FFD-44B2-A4AB-7B479121BB5EQ24187809-BF870BB7-12CD-4961-B6F4-70872E3A17B0
P2860
description
1960 nî lūn-bûn
@nan
1960 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1960 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1960年の論文
@ja
1960年学术文章
@wuu
1960年学术文章
@zh-cn
1960年学术文章
@zh-hans
1960年学术文章
@zh-my
1960年学术文章
@zh-sg
1960年學術文章
@yue
name
A rating scale for depression
@ast
A rating scale for depression
@en
A rating scale for depression
@nl
type
label
A rating scale for depression
@ast
A rating scale for depression
@en
A rating scale for depression
@nl
altLabel
A RATING SCALE FOR DEPRESSION
@en
prefLabel
A rating scale for depression
@ast
A rating scale for depression
@en
A rating scale for depression
@nl
P3181
P356
P1476
A rating scale for depression
@en
P2093
M HAMILTON
P3181
P356
10.1136/JNNP.23.1.56
P407
P577
1960-02-01T00:00:00Z